FIELD: chemistry.
SUBSTANCE: invention refers to using 1-hydroxyhermatrane monohydrate (hermatranol hydrate) of formula 
for stimulating tryptophanyl-tRNA-synthetase matrix RNA expression.
EFFECT: improving the method.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF PROTATRANE 4-CHLORO-2-METHYLPHENOXIACETATE (CHLORCREZACINE) FOR TRYPTOPHANYL-tRNA-SYNTHETASE MATRIX RNA EXPRESSION STIMULATION | 2016 |
|
RU2623035C1 |
| USING ZINC COMPLEX-TRIS-(2-HYDROXYETHYL)AMINE WITH BIS-(2-METHYLPHENOXYACETATE) (ZINCATRANE) FOR STIMULATING EXPRESSION OF MATRIX RNA OF TRYPTOPHANYL-tRNA-SYNTHETASE | 2014 |
|
RU2540469C1 |
| AGENT STIMULATING EXPRESSION OF MATRIX RNA OF TRYPTOPHANYL-tRNA-SYNTHETASE | 2010 |
|
RU2429836C1 |
| AGENT FOR TOTAL TRYPTOPHANYL-tRNS-SYNTHETASE ACTIVATION | 2009 |
|
RU2407526C1 |
| METHOD OF ASSESSMENT OF GENE EXPRESSION OF TRYPTOPHANYL - TOTAL RNA SYNTHETASE AS MARKER OF OVERWORK DURING TRAINING OF ATHLETES - STATE OF OVERTRAINING | 2013 |
|
RU2521655C1 |
| METHOD TO PRODUCE MODIFIED FORM OF TRYPTOPHANYL-tRNA-SYNTHETASE | 2012 |
|
RU2495123C2 |
| METHOD FOR INHIBITION OF MALIGNANT TUMOUR METASTASIS OR MALIGNANT CELL MIGRATION BY REDUCING CELL LEVEL OF LYSYL-tRNA-SYNTHETASE (VERSIONS), COMPOSITION AND APPLICATION OF EXPRESSION VECTOR OR KRS ANTIBODY FOR INHIBITION OF MALIGNANT TUMOUR METASTASIS OR MALIGNANT CELL MIGRATION | 2008 |
|
RU2465330C1 |
| 1-HYDROXYGERMATRANE USAGE FOR INHIBITING THE DEVELOPMENT OF ATHEROSCLEROSIS IN THE EXPERIMENT | 2020 |
|
RU2742972C1 |
| USING COMPLEX OF TRIS-(2-HYDROXYETHYL)AMINE AND ZINC BIS-(2-METHYLPHENOXYACETATE) (CINKATRAN) AS AGENT SUPPRESSING TOTAL ACTIVITY OF BASIC (ALKALINE) MONONUCLEAR PHOSPHOLIPASE A2 | 2014 |
|
RU2546537C1 |
| METHOD FOR CORRECTING ATHEROGENESIS EXPERIMENTALLY USING 1-HYDROXYGERMATRANE | 2020 |
|
RU2741229C1 |
